Medical device companies started spending cash immediately after 2021 began, racking up at least 10 deals in January alone, and the industry has not stopped spending since.
The number of acquisitions has continued to pile up heading into the final months of the year, with M&A activity ranging from smaller buy-outs to Baxter's $10.5 billion takeover of Hillrom. With five deals already announced, two of which eclipsed $1 billion, Boston Scientific has been one of the most active companies in the space.
A series of pickups in the cardiac monitoring submarket, multiples deals in diagnostics and SPAC mergers have been standout themes over the last nine months.
Analysts expected to see a strong rebound in M&A activity this year after companies largely held on to cash throughout the unpredictability of 2020, and medtechs have so far lived up to those expectations.
Below is a collection of acquisitions that MedTech Dive has covered and tracked throughout the year. We'll update this space as new deals emerge.